Pharma & Healthcare
Global Chronic Urticaria Medicine Market Research Report 2026
- Mar 17, 26
- ID: 736990
- Pages: 121
- Figures: 118
- Views: 6
This report delivers a comprehensive overview of the global Chronic Urticaria Medicine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Chronic Urticaria Medicine. The Chronic Urticaria Medicine market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Chronic Urticaria Medicine market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Chronic Urticaria Medicine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Johnson & Johnson
Merck
Fresenius
3SBIO
SPHBIO
Sun Pharmaceutical Industries
Yangtze River Pharmaceutical Group
CSPC Pharmaceutical Group
Shanxi C&Y Pharmaceutical Group
Lianhuan Pharma
Jiudian Pharmaceutical
Segment by Type
Loratadine
Desloratadine
Fexofenadine
Ebastine
Stastine
Cetirizine
Levocetirizine
Cinnarizine
Other
by Application
Hospital and Clinic
Specialist Medical Centre
Retail Pharmacies
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Chronic Urticaria Medicine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Chronic Urticaria Medicine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Chronic Urticaria Medicine market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Chronic Urticaria Medicine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Johnson & Johnson
Merck
Fresenius
3SBIO
SPHBIO
Sun Pharmaceutical Industries
Yangtze River Pharmaceutical Group
CSPC Pharmaceutical Group
Shanxi C&Y Pharmaceutical Group
Lianhuan Pharma
Jiudian Pharmaceutical
Segment by Type
Loratadine
Desloratadine
Fexofenadine
Ebastine
Stastine
Cetirizine
Levocetirizine
Cinnarizine
Other
by Application
Hospital and Clinic
Specialist Medical Centre
Retail Pharmacies
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Chronic Urticaria Medicine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Chronic Urticaria Medicine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Chronic Urticaria Medicine Market Overview
1.1 Product Definition
1.2 Chronic Urticaria Medicine by Type
1.2.1 Global Chronic Urticaria Medicine Market Value by Type: 2025 vs 2032
1.2.2 Loratadine
1.2.3 Desloratadine
1.2.4 Fexofenadine
1.2.5 Ebastine
1.2.6 Stastine
1.2.7 Cetirizine
1.2.8 Levocetirizine
1.2.9 Cinnarizine
1.2.10 Other
1.3 Chronic Urticaria Medicine by Application
1.3.1 Global Chronic Urticaria Medicine Market Value by Application: 2025 vs 2032
1.3.2 Hospital and Clinic
1.3.3 Specialist Medical Centre
1.3.4 Retail Pharmacies
1.3.5 Other
1.4 Global Chronic Urticaria Medicine Market Size Estimates and Forecasts
1.4.1 Global Chronic Urticaria Medicine Revenue 2021–2032
1.4.2 Global Chronic Urticaria Medicine Sales 2021–2032
1.4.3 Global Chronic Urticaria Medicine Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Chronic Urticaria Medicine Market Competition by Manufacturers
2.1 Global Chronic Urticaria Medicine Sales Market Share by Manufacturers (2021–2026)
2.2 Global Chronic Urticaria Medicine Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Chronic Urticaria Medicine Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Chronic Urticaria Medicine, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Chronic Urticaria Medicine, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Chronic Urticaria Medicine, Product Types and Applications
2.7 Global Key Manufacturers of Chronic Urticaria Medicine, Date of Entry into the Industry
2.8 Global Chronic Urticaria Medicine Market Competitive Situation and Trends
2.8.1 Global Chronic Urticaria Medicine Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Chronic Urticaria Medicine Players Market Share by Revenue
2.8.3 Global Chronic Urticaria Medicine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Chronic Urticaria Medicine Market Scenario by Region
3.1 Global Chronic Urticaria Medicine Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Chronic Urticaria Medicine Sales by Region: 2021–2032
3.2.1 Global Chronic Urticaria Medicine Sales by Region: 2021–2026
3.2.2 Global Chronic Urticaria Medicine Sales by Region: 2027–2032
3.3 Global Chronic Urticaria Medicine Revenue by Region: 2021–2032
3.3.1 Global Chronic Urticaria Medicine Revenue by Region: 2021–2026
3.3.2 Global Chronic Urticaria Medicine Revenue by Region: 2027–2032
3.4 North America Chronic Urticaria Medicine Market Facts & Figures by Country
3.4.1 North America Chronic Urticaria Medicine Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Chronic Urticaria Medicine Sales by Country (2021–2032)
3.4.3 North America Chronic Urticaria Medicine Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Chronic Urticaria Medicine Market Facts & Figures by Country
3.5.1 Europe Chronic Urticaria Medicine Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Chronic Urticaria Medicine Sales by Country (2021–2032)
3.5.3 Europe Chronic Urticaria Medicine Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Chronic Urticaria Medicine Market Facts & Figures by Region
3.6.1 Asia Pacific Chronic Urticaria Medicine Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Chronic Urticaria Medicine Sales by Region (2021–2032)
3.6.3 Asia Pacific Chronic Urticaria Medicine Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Chronic Urticaria Medicine Market Facts & Figures by Country
3.7.1 Latin America Chronic Urticaria Medicine Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Chronic Urticaria Medicine Sales by Country (2021–2032)
3.7.3 Latin America Chronic Urticaria Medicine Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Chronic Urticaria Medicine Market Facts & Figures by Country
3.8.1 Middle East and Africa Chronic Urticaria Medicine Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Chronic Urticaria Medicine Sales by Country (2021–2032)
3.8.3 Middle East and Africa Chronic Urticaria Medicine Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Chronic Urticaria Medicine Sales by Type (2021–2032)
4.1.1 Global Chronic Urticaria Medicine Sales by Type (2021–2026)
4.1.2 Global Chronic Urticaria Medicine Sales by Type (2027–2032)
4.1.3 Global Chronic Urticaria Medicine Sales Market Share by Type (2021–2032)
4.2 Global Chronic Urticaria Medicine Revenue by Type (2021–2032)
4.2.1 Global Chronic Urticaria Medicine Revenue by Type (2021–2026)
4.2.2 Global Chronic Urticaria Medicine Revenue by Type (2027–2032)
4.2.3 Global Chronic Urticaria Medicine Revenue Market Share by Type (2021–2032)
4.3 Global Chronic Urticaria Medicine Price by Type (2021–2032)
5 Segment by Application
5.1 Global Chronic Urticaria Medicine Sales by Application (2021–2032)
5.1.1 Global Chronic Urticaria Medicine Sales by Application (2021–2026)
5.1.2 Global Chronic Urticaria Medicine Sales by Application (2027–2032)
5.1.3 Global Chronic Urticaria Medicine Sales Market Share by Application (2021–2032)
5.2 Global Chronic Urticaria Medicine Revenue by Application (2021–2032)
5.2.1 Global Chronic Urticaria Medicine Revenue by Application (2021–2026)
5.2.2 Global Chronic Urticaria Medicine Revenue by Application (2027–2032)
5.2.3 Global Chronic Urticaria Medicine Revenue Market Share by Application (2021–2032)
5.3 Global Chronic Urticaria Medicine Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Company Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Chronic Urticaria Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Johnson & Johnson Chronic Urticaria Medicine Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Merck
6.2.1 Merck Company Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Chronic Urticaria Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Merck Chronic Urticaria Medicine Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Fresenius
6.3.1 Fresenius Company Information
6.3.2 Fresenius Description and Business Overview
6.3.3 Fresenius Chronic Urticaria Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Fresenius Chronic Urticaria Medicine Product Portfolio
6.3.5 Fresenius Recent Developments/Updates
6.4 3SBIO
6.4.1 3SBIO Company Information
6.4.2 3SBIO Description and Business Overview
6.4.3 3SBIO Chronic Urticaria Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 3SBIO Chronic Urticaria Medicine Product Portfolio
6.4.5 3SBIO Recent Developments/Updates
6.5 SPHBIO
6.5.1 SPHBIO Company Information
6.5.2 SPHBIO Description and Business Overview
6.5.3 SPHBIO Chronic Urticaria Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 SPHBIO Chronic Urticaria Medicine Product Portfolio
6.5.5 SPHBIO Recent Developments/Updates
6.6 Sun Pharmaceutical Industries
6.6.1 Sun Pharmaceutical Industries Company Information
6.6.2 Sun Pharmaceutical Industries Description and Business Overview
6.6.3 Sun Pharmaceutical Industries Chronic Urticaria Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Sun Pharmaceutical Industries Chronic Urticaria Medicine Product Portfolio
6.6.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.7 Yangtze River Pharmaceutical Group
6.7.1 Yangtze River Pharmaceutical Group Company Information
6.7.2 Yangtze River Pharmaceutical Group Description and Business Overview
6.7.3 Yangtze River Pharmaceutical Group Chronic Urticaria Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Yangtze River Pharmaceutical Group Chronic Urticaria Medicine Product Portfolio
6.7.5 Yangtze River Pharmaceutical Group Recent Developments/Updates
6.8 CSPC Pharmaceutical Group
6.8.1 CSPC Pharmaceutical Group Company Information
6.8.2 CSPC Pharmaceutical Group Description and Business Overview
6.8.3 CSPC Pharmaceutical Group Chronic Urticaria Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 CSPC Pharmaceutical Group Chronic Urticaria Medicine Product Portfolio
6.8.5 CSPC Pharmaceutical Group Recent Developments/Updates
6.9 Shanxi C&Y Pharmaceutical Group
6.9.1 Shanxi C&Y Pharmaceutical Group Company Information
6.9.2 Shanxi C&Y Pharmaceutical Group Description and Business Overview
6.9.3 Shanxi C&Y Pharmaceutical Group Chronic Urticaria Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Shanxi C&Y Pharmaceutical Group Chronic Urticaria Medicine Product Portfolio
6.9.5 Shanxi C&Y Pharmaceutical Group Recent Developments/Updates
6.10 Lianhuan Pharma
6.10.1 Lianhuan Pharma Company Information
6.10.2 Lianhuan Pharma Description and Business Overview
6.10.3 Lianhuan Pharma Chronic Urticaria Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Lianhuan Pharma Chronic Urticaria Medicine Product Portfolio
6.10.5 Lianhuan Pharma Recent Developments/Updates
6.11 Jiudian Pharmaceutical
6.11.1 Jiudian Pharmaceutical Company Information
6.11.2 Jiudian Pharmaceutical Description and Business Overview
6.11.3 Jiudian Pharmaceutical Chronic Urticaria Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Jiudian Pharmaceutical Chronic Urticaria Medicine Product Portfolio
6.11.5 Jiudian Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Chronic Urticaria Medicine Industry Chain Analysis
7.2 Chronic Urticaria Medicine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Chronic Urticaria Medicine Production Mode & Process Analysis
7.4 Chronic Urticaria Medicine Sales and Marketing
7.4.1 Chronic Urticaria Medicine Sales Channels
7.4.2 Chronic Urticaria Medicine Distributors
7.5 Chronic Urticaria Medicine Customer Analysis
8 Chronic Urticaria Medicine Market Dynamics
8.1 Chronic Urticaria Medicine Industry Trends
8.2 Chronic Urticaria Medicine Market Drivers
8.3 Chronic Urticaria Medicine Market Challenges
8.4 Chronic Urticaria Medicine Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Chronic Urticaria Medicine by Type
1.2.1 Global Chronic Urticaria Medicine Market Value by Type: 2025 vs 2032
1.2.2 Loratadine
1.2.3 Desloratadine
1.2.4 Fexofenadine
1.2.5 Ebastine
1.2.6 Stastine
1.2.7 Cetirizine
1.2.8 Levocetirizine
1.2.9 Cinnarizine
1.2.10 Other
1.3 Chronic Urticaria Medicine by Application
1.3.1 Global Chronic Urticaria Medicine Market Value by Application: 2025 vs 2032
1.3.2 Hospital and Clinic
1.3.3 Specialist Medical Centre
1.3.4 Retail Pharmacies
1.3.5 Other
1.4 Global Chronic Urticaria Medicine Market Size Estimates and Forecasts
1.4.1 Global Chronic Urticaria Medicine Revenue 2021–2032
1.4.2 Global Chronic Urticaria Medicine Sales 2021–2032
1.4.3 Global Chronic Urticaria Medicine Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Chronic Urticaria Medicine Market Competition by Manufacturers
2.1 Global Chronic Urticaria Medicine Sales Market Share by Manufacturers (2021–2026)
2.2 Global Chronic Urticaria Medicine Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Chronic Urticaria Medicine Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Chronic Urticaria Medicine, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Chronic Urticaria Medicine, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Chronic Urticaria Medicine, Product Types and Applications
2.7 Global Key Manufacturers of Chronic Urticaria Medicine, Date of Entry into the Industry
2.8 Global Chronic Urticaria Medicine Market Competitive Situation and Trends
2.8.1 Global Chronic Urticaria Medicine Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Chronic Urticaria Medicine Players Market Share by Revenue
2.8.3 Global Chronic Urticaria Medicine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Chronic Urticaria Medicine Market Scenario by Region
3.1 Global Chronic Urticaria Medicine Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Chronic Urticaria Medicine Sales by Region: 2021–2032
3.2.1 Global Chronic Urticaria Medicine Sales by Region: 2021–2026
3.2.2 Global Chronic Urticaria Medicine Sales by Region: 2027–2032
3.3 Global Chronic Urticaria Medicine Revenue by Region: 2021–2032
3.3.1 Global Chronic Urticaria Medicine Revenue by Region: 2021–2026
3.3.2 Global Chronic Urticaria Medicine Revenue by Region: 2027–2032
3.4 North America Chronic Urticaria Medicine Market Facts & Figures by Country
3.4.1 North America Chronic Urticaria Medicine Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Chronic Urticaria Medicine Sales by Country (2021–2032)
3.4.3 North America Chronic Urticaria Medicine Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Chronic Urticaria Medicine Market Facts & Figures by Country
3.5.1 Europe Chronic Urticaria Medicine Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Chronic Urticaria Medicine Sales by Country (2021–2032)
3.5.3 Europe Chronic Urticaria Medicine Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Chronic Urticaria Medicine Market Facts & Figures by Region
3.6.1 Asia Pacific Chronic Urticaria Medicine Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Chronic Urticaria Medicine Sales by Region (2021–2032)
3.6.3 Asia Pacific Chronic Urticaria Medicine Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Chronic Urticaria Medicine Market Facts & Figures by Country
3.7.1 Latin America Chronic Urticaria Medicine Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Chronic Urticaria Medicine Sales by Country (2021–2032)
3.7.3 Latin America Chronic Urticaria Medicine Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Chronic Urticaria Medicine Market Facts & Figures by Country
3.8.1 Middle East and Africa Chronic Urticaria Medicine Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Chronic Urticaria Medicine Sales by Country (2021–2032)
3.8.3 Middle East and Africa Chronic Urticaria Medicine Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Chronic Urticaria Medicine Sales by Type (2021–2032)
4.1.1 Global Chronic Urticaria Medicine Sales by Type (2021–2026)
4.1.2 Global Chronic Urticaria Medicine Sales by Type (2027–2032)
4.1.3 Global Chronic Urticaria Medicine Sales Market Share by Type (2021–2032)
4.2 Global Chronic Urticaria Medicine Revenue by Type (2021–2032)
4.2.1 Global Chronic Urticaria Medicine Revenue by Type (2021–2026)
4.2.2 Global Chronic Urticaria Medicine Revenue by Type (2027–2032)
4.2.3 Global Chronic Urticaria Medicine Revenue Market Share by Type (2021–2032)
4.3 Global Chronic Urticaria Medicine Price by Type (2021–2032)
5 Segment by Application
5.1 Global Chronic Urticaria Medicine Sales by Application (2021–2032)
5.1.1 Global Chronic Urticaria Medicine Sales by Application (2021–2026)
5.1.2 Global Chronic Urticaria Medicine Sales by Application (2027–2032)
5.1.3 Global Chronic Urticaria Medicine Sales Market Share by Application (2021–2032)
5.2 Global Chronic Urticaria Medicine Revenue by Application (2021–2032)
5.2.1 Global Chronic Urticaria Medicine Revenue by Application (2021–2026)
5.2.2 Global Chronic Urticaria Medicine Revenue by Application (2027–2032)
5.2.3 Global Chronic Urticaria Medicine Revenue Market Share by Application (2021–2032)
5.3 Global Chronic Urticaria Medicine Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Company Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Chronic Urticaria Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Johnson & Johnson Chronic Urticaria Medicine Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Merck
6.2.1 Merck Company Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Chronic Urticaria Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Merck Chronic Urticaria Medicine Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Fresenius
6.3.1 Fresenius Company Information
6.3.2 Fresenius Description and Business Overview
6.3.3 Fresenius Chronic Urticaria Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Fresenius Chronic Urticaria Medicine Product Portfolio
6.3.5 Fresenius Recent Developments/Updates
6.4 3SBIO
6.4.1 3SBIO Company Information
6.4.2 3SBIO Description and Business Overview
6.4.3 3SBIO Chronic Urticaria Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 3SBIO Chronic Urticaria Medicine Product Portfolio
6.4.5 3SBIO Recent Developments/Updates
6.5 SPHBIO
6.5.1 SPHBIO Company Information
6.5.2 SPHBIO Description and Business Overview
6.5.3 SPHBIO Chronic Urticaria Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 SPHBIO Chronic Urticaria Medicine Product Portfolio
6.5.5 SPHBIO Recent Developments/Updates
6.6 Sun Pharmaceutical Industries
6.6.1 Sun Pharmaceutical Industries Company Information
6.6.2 Sun Pharmaceutical Industries Description and Business Overview
6.6.3 Sun Pharmaceutical Industries Chronic Urticaria Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Sun Pharmaceutical Industries Chronic Urticaria Medicine Product Portfolio
6.6.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.7 Yangtze River Pharmaceutical Group
6.7.1 Yangtze River Pharmaceutical Group Company Information
6.7.2 Yangtze River Pharmaceutical Group Description and Business Overview
6.7.3 Yangtze River Pharmaceutical Group Chronic Urticaria Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Yangtze River Pharmaceutical Group Chronic Urticaria Medicine Product Portfolio
6.7.5 Yangtze River Pharmaceutical Group Recent Developments/Updates
6.8 CSPC Pharmaceutical Group
6.8.1 CSPC Pharmaceutical Group Company Information
6.8.2 CSPC Pharmaceutical Group Description and Business Overview
6.8.3 CSPC Pharmaceutical Group Chronic Urticaria Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 CSPC Pharmaceutical Group Chronic Urticaria Medicine Product Portfolio
6.8.5 CSPC Pharmaceutical Group Recent Developments/Updates
6.9 Shanxi C&Y Pharmaceutical Group
6.9.1 Shanxi C&Y Pharmaceutical Group Company Information
6.9.2 Shanxi C&Y Pharmaceutical Group Description and Business Overview
6.9.3 Shanxi C&Y Pharmaceutical Group Chronic Urticaria Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Shanxi C&Y Pharmaceutical Group Chronic Urticaria Medicine Product Portfolio
6.9.5 Shanxi C&Y Pharmaceutical Group Recent Developments/Updates
6.10 Lianhuan Pharma
6.10.1 Lianhuan Pharma Company Information
6.10.2 Lianhuan Pharma Description and Business Overview
6.10.3 Lianhuan Pharma Chronic Urticaria Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Lianhuan Pharma Chronic Urticaria Medicine Product Portfolio
6.10.5 Lianhuan Pharma Recent Developments/Updates
6.11 Jiudian Pharmaceutical
6.11.1 Jiudian Pharmaceutical Company Information
6.11.2 Jiudian Pharmaceutical Description and Business Overview
6.11.3 Jiudian Pharmaceutical Chronic Urticaria Medicine Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Jiudian Pharmaceutical Chronic Urticaria Medicine Product Portfolio
6.11.5 Jiudian Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Chronic Urticaria Medicine Industry Chain Analysis
7.2 Chronic Urticaria Medicine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Chronic Urticaria Medicine Production Mode & Process Analysis
7.4 Chronic Urticaria Medicine Sales and Marketing
7.4.1 Chronic Urticaria Medicine Sales Channels
7.4.2 Chronic Urticaria Medicine Distributors
7.5 Chronic Urticaria Medicine Customer Analysis
8 Chronic Urticaria Medicine Market Dynamics
8.1 Chronic Urticaria Medicine Industry Trends
8.2 Chronic Urticaria Medicine Market Drivers
8.3 Chronic Urticaria Medicine Market Challenges
8.4 Chronic Urticaria Medicine Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Chronic Urticaria Medicine Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Chronic Urticaria Medicine Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Chronic Urticaria Medicine Market Competitive Situation by Manufacturers in 2025
Table 4. Global Chronic Urticaria Medicine Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Chronic Urticaria Medicine Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Chronic Urticaria Medicine Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Chronic Urticaria Medicine Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Chronic Urticaria Medicine Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Chronic Urticaria Medicine, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Chronic Urticaria Medicine, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Chronic Urticaria Medicine, Product Types and Applications
Table 12. Global Key Manufacturers of Chronic Urticaria Medicine, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Chronic Urticaria Medicine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Chronic Urticaria Medicine Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Chronic Urticaria Medicine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Chronic Urticaria Medicine Sales by Region (K Units), 2021–2026
Table 18. Global Chronic Urticaria Medicine Sales Market Share by Region (2021–2026)
Table 19. Global Chronic Urticaria Medicine Sales by Region (K Units), 2027–2032
Table 20. Global Chronic Urticaria Medicine Sales Market Share by Region (2027–2032)
Table 21. Global Chronic Urticaria Medicine Revenue by Region (US$ Million), 2021–2026
Table 22. Global Chronic Urticaria Medicine Revenue Market Share by Region (2021–2026)
Table 23. Global Chronic Urticaria Medicine Revenue by Region (US$ Million), 2027–2032
Table 24. Global Chronic Urticaria Medicine Revenue Market Share by Region (2027–2032)
Table 25. North America Chronic Urticaria Medicine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Chronic Urticaria Medicine Sales by Country (K Units), 2021–2026
Table 27. North America Chronic Urticaria Medicine Sales by Country (K Units), 2027–2032
Table 28. North America Chronic Urticaria Medicine Revenue by Country (US$ Million), 2021–2026
Table 29. North America Chronic Urticaria Medicine Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Chronic Urticaria Medicine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Chronic Urticaria Medicine Sales by Country (K Units), 2021–2026
Table 32. Europe Chronic Urticaria Medicine Sales by Country (K Units), 2027–2032
Table 33. Europe Chronic Urticaria Medicine Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Chronic Urticaria Medicine Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Chronic Urticaria Medicine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Chronic Urticaria Medicine Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Chronic Urticaria Medicine Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Chronic Urticaria Medicine Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Chronic Urticaria Medicine Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Chronic Urticaria Medicine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Chronic Urticaria Medicine Sales by Country (K Units), 2021–2026
Table 42. Latin America Chronic Urticaria Medicine Sales by Country (K Units), 2027–2032
Table 43. Latin America Chronic Urticaria Medicine Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Chronic Urticaria Medicine Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Chronic Urticaria Medicine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Chronic Urticaria Medicine Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Chronic Urticaria Medicine Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Chronic Urticaria Medicine Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Chronic Urticaria Medicine Revenue by Country (US$ Million), 2027–2032
Table 50. Global Chronic Urticaria Medicine Sales (K Units) by Type (2021–2026)
Table 51. Global Chronic Urticaria Medicine Sales (K Units) by Type (2027–2032)
Table 52. Global Chronic Urticaria Medicine Sales Market Share by Type (2021–2026)
Table 53. Global Chronic Urticaria Medicine Sales Market Share by Type (2027–2032)
Table 54. Global Chronic Urticaria Medicine Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Chronic Urticaria Medicine Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Chronic Urticaria Medicine Revenue Market Share by Type (2021–2026)
Table 57. Global Chronic Urticaria Medicine Revenue Market Share by Type (2027–2032)
Table 58. Global Chronic Urticaria Medicine Price (US$/Unit) by Type (2021–2026)
Table 59. Global Chronic Urticaria Medicine Price (US$/Unit) by Type (2027–2032)
Table 60. Global Chronic Urticaria Medicine Sales (K Units) by Application (2021–2026)
Table 61. Global Chronic Urticaria Medicine Sales (K Units) by Application (2027–2032)
Table 62. Global Chronic Urticaria Medicine Sales Market Share by Application (2021–2026)
Table 63. Global Chronic Urticaria Medicine Sales Market Share by Application (2027–2032)
Table 64. Global Chronic Urticaria Medicine Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Chronic Urticaria Medicine Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Chronic Urticaria Medicine Revenue Market Share by Application (2021–2026)
Table 67. Global Chronic Urticaria Medicine Revenue Market Share by Application (2027–2032)
Table 68. Global Chronic Urticaria Medicine Price (US$/Unit) by Application (2021–2026)
Table 69. Global Chronic Urticaria Medicine Price (US$/Unit) by Application (2027–2032)
Table 70. Johnson & Johnson Company Information
Table 71. Johnson & Johnson Description and Business Overview
Table 72. Johnson & Johnson Chronic Urticaria Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Johnson & Johnson Chronic Urticaria Medicine Product
Table 74. Johnson & Johnson Recent Developments/Updates
Table 75. Merck Company Information
Table 76. Merck Description and Business Overview
Table 77. Merck Chronic Urticaria Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Merck Chronic Urticaria Medicine Product
Table 79. Merck Recent Developments/Updates
Table 80. Fresenius Company Information
Table 81. Fresenius Description and Business Overview
Table 82. Fresenius Chronic Urticaria Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Fresenius Chronic Urticaria Medicine Product
Table 84. Fresenius Recent Developments/Updates
Table 85. 3SBIO Company Information
Table 86. 3SBIO Description and Business Overview
Table 87. 3SBIO Chronic Urticaria Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. 3SBIO Chronic Urticaria Medicine Product
Table 89. 3SBIO Recent Developments/Updates
Table 90. SPHBIO Company Information
Table 91. SPHBIO Description and Business Overview
Table 92. SPHBIO Chronic Urticaria Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. SPHBIO Chronic Urticaria Medicine Product
Table 94. SPHBIO Recent Developments/Updates
Table 95. Sun Pharmaceutical Industries Company Information
Table 96. Sun Pharmaceutical Industries Description and Business Overview
Table 97. Sun Pharmaceutical Industries Chronic Urticaria Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Sun Pharmaceutical Industries Chronic Urticaria Medicine Product
Table 99. Sun Pharmaceutical Industries Recent Developments/Updates
Table 100. Yangtze River Pharmaceutical Group Company Information
Table 101. Yangtze River Pharmaceutical Group Description and Business Overview
Table 102. Yangtze River Pharmaceutical Group Chronic Urticaria Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Yangtze River Pharmaceutical Group Chronic Urticaria Medicine Product
Table 104. Yangtze River Pharmaceutical Group Recent Developments/Updates
Table 105. CSPC Pharmaceutical Group Company Information
Table 106. CSPC Pharmaceutical Group Description and Business Overview
Table 107. CSPC Pharmaceutical Group Chronic Urticaria Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. CSPC Pharmaceutical Group Chronic Urticaria Medicine Product
Table 109. CSPC Pharmaceutical Group Recent Developments/Updates
Table 110. Shanxi C&Y Pharmaceutical Group Company Information
Table 111. Shanxi C&Y Pharmaceutical Group Description and Business Overview
Table 112. Shanxi C&Y Pharmaceutical Group Chronic Urticaria Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Shanxi C&Y Pharmaceutical Group Chronic Urticaria Medicine Product
Table 114. Shanxi C&Y Pharmaceutical Group Recent Developments/Updates
Table 115. Lianhuan Pharma Company Information
Table 116. Lianhuan Pharma Description and Business Overview
Table 117. Lianhuan Pharma Chronic Urticaria Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Lianhuan Pharma Chronic Urticaria Medicine Product
Table 119. Lianhuan Pharma Recent Developments/Updates
Table 120. Jiudian Pharmaceutical Company Information
Table 121. Jiudian Pharmaceutical Description and Business Overview
Table 122. Jiudian Pharmaceutical Chronic Urticaria Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Jiudian Pharmaceutical Chronic Urticaria Medicine Product
Table 124. Jiudian Pharmaceutical Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Chronic Urticaria Medicine Distributors List
Table 128. Chronic Urticaria Medicine Customers List
Table 129. Chronic Urticaria Medicine Market Trends
Table 130. Chronic Urticaria Medicine Market Drivers
Table 131. Chronic Urticaria Medicine Market Challenges
Table 132. Chronic Urticaria Medicine Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Chronic Urticaria Medicine
Figure 2. Global Chronic Urticaria Medicine Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Chronic Urticaria Medicine Market Share by Type: 2025 & 2032
Figure 4. Loratadine Product Picture
Figure 5. Desloratadine Product Picture
Figure 6. Fexofenadine Product Picture
Figure 7. Ebastine Product Picture
Figure 8. Stastine Product Picture
Figure 9. Cetirizine Product Picture
Figure 10. Levocetirizine Product Picture
Figure 11. Cinnarizine Product Picture
Figure 12. Other Product Picture
Figure 13. Global Chronic Urticaria Medicine Market Value by Application (US$ Million), 2021–2032
Figure 14. Global Chronic Urticaria Medicine Market Share by Application: 2025 & 2032
Figure 15. Hospital and Clinic
Figure 16. Specialist Medical Centre
Figure 17. Retail Pharmacies
Figure 18. Other
Figure 19. Global Chronic Urticaria Medicine Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 20. Global Chronic Urticaria Medicine Market Size (US$ Million), 2021–2032
Figure 21. Global Chronic Urticaria Medicine Sales (K Units), 2021–2032
Figure 22. Global Chronic Urticaria Medicine Average Price (US$/Unit), 2021–2032
Figure 23. Chronic Urticaria Medicine Report Years Considered
Figure 24. Chronic Urticaria Medicine Sales Share by Manufacturers in 2025
Figure 25. Global Chronic Urticaria Medicine Revenue Share by Manufacturers in 2025
Figure 26. Top 5 and Top 10 Global Chronic Urticaria Medicine Players: Market Share by Revenue in Chronic Urticaria Medicine in 2025
Figure 27. Chronic Urticaria Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 28. Global Chronic Urticaria Medicine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 29. North America Chronic Urticaria Medicine Sales Market Share by Country (2021–2032)
Figure 30. North America Chronic Urticaria Medicine Revenue Market Share by Country (2021–2032)
Figure 31. United States Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Canada Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Europe Chronic Urticaria Medicine Sales Market Share by Country (2021–2032)
Figure 34. Europe Chronic Urticaria Medicine Revenue Market Share by Country (2021–2032)
Figure 35. Germany Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. France Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. U.K. Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Italy Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Russia Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Asia Pacific Chronic Urticaria Medicine Sales Market Share by Region (2021–2032)
Figure 41. Asia Pacific Chronic Urticaria Medicine Revenue Market Share by Region (2021–2032)
Figure 42. China Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Japan Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. South Korea Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. India Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Australia Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. China Taiwan Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Southeast Asia Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Latin America Chronic Urticaria Medicine Sales Market Share by Country (2021–2032)
Figure 50. Latin America Chronic Urticaria Medicine Revenue Market Share by Country (2021–2032)
Figure 51. Mexico Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Brazil Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Argentina Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Colombia Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Middle East and Africa Chronic Urticaria Medicine Sales Market Share by Country (2021–2032)
Figure 56. Middle East and Africa Chronic Urticaria Medicine Revenue Market Share by Country (2021–2032)
Figure 57. Turkey Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Saudi Arabia Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 59. UAE Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 60. Global Sales Market Share of Chronic Urticaria Medicine by Type (2021–2032)
Figure 61. Global Revenue Market Share of Chronic Urticaria Medicine by Type (2021–2032)
Figure 62. Global Chronic Urticaria Medicine Price (US$/Unit) by Type (2021–2032)
Figure 63. Global Sales Market Share of Chronic Urticaria Medicine by Application (2021–2032)
Figure 64. Global Revenue Market Share of Chronic Urticaria Medicine by Application (2021–2032)
Figure 65. Global Chronic Urticaria Medicine Price (US$/Unit) by Application (2021–2032)
Figure 66. Chronic Urticaria Medicine Value Chain
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Table 1. Global Chronic Urticaria Medicine Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Chronic Urticaria Medicine Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Chronic Urticaria Medicine Market Competitive Situation by Manufacturers in 2025
Table 4. Global Chronic Urticaria Medicine Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Chronic Urticaria Medicine Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Chronic Urticaria Medicine Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Chronic Urticaria Medicine Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Chronic Urticaria Medicine Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Chronic Urticaria Medicine, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Chronic Urticaria Medicine, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Chronic Urticaria Medicine, Product Types and Applications
Table 12. Global Key Manufacturers of Chronic Urticaria Medicine, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Chronic Urticaria Medicine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Chronic Urticaria Medicine Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Chronic Urticaria Medicine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Chronic Urticaria Medicine Sales by Region (K Units), 2021–2026
Table 18. Global Chronic Urticaria Medicine Sales Market Share by Region (2021–2026)
Table 19. Global Chronic Urticaria Medicine Sales by Region (K Units), 2027–2032
Table 20. Global Chronic Urticaria Medicine Sales Market Share by Region (2027–2032)
Table 21. Global Chronic Urticaria Medicine Revenue by Region (US$ Million), 2021–2026
Table 22. Global Chronic Urticaria Medicine Revenue Market Share by Region (2021–2026)
Table 23. Global Chronic Urticaria Medicine Revenue by Region (US$ Million), 2027–2032
Table 24. Global Chronic Urticaria Medicine Revenue Market Share by Region (2027–2032)
Table 25. North America Chronic Urticaria Medicine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Chronic Urticaria Medicine Sales by Country (K Units), 2021–2026
Table 27. North America Chronic Urticaria Medicine Sales by Country (K Units), 2027–2032
Table 28. North America Chronic Urticaria Medicine Revenue by Country (US$ Million), 2021–2026
Table 29. North America Chronic Urticaria Medicine Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Chronic Urticaria Medicine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Chronic Urticaria Medicine Sales by Country (K Units), 2021–2026
Table 32. Europe Chronic Urticaria Medicine Sales by Country (K Units), 2027–2032
Table 33. Europe Chronic Urticaria Medicine Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Chronic Urticaria Medicine Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Chronic Urticaria Medicine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Chronic Urticaria Medicine Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Chronic Urticaria Medicine Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Chronic Urticaria Medicine Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Chronic Urticaria Medicine Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Chronic Urticaria Medicine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Chronic Urticaria Medicine Sales by Country (K Units), 2021–2026
Table 42. Latin America Chronic Urticaria Medicine Sales by Country (K Units), 2027–2032
Table 43. Latin America Chronic Urticaria Medicine Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Chronic Urticaria Medicine Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Chronic Urticaria Medicine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Chronic Urticaria Medicine Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Chronic Urticaria Medicine Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Chronic Urticaria Medicine Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Chronic Urticaria Medicine Revenue by Country (US$ Million), 2027–2032
Table 50. Global Chronic Urticaria Medicine Sales (K Units) by Type (2021–2026)
Table 51. Global Chronic Urticaria Medicine Sales (K Units) by Type (2027–2032)
Table 52. Global Chronic Urticaria Medicine Sales Market Share by Type (2021–2026)
Table 53. Global Chronic Urticaria Medicine Sales Market Share by Type (2027–2032)
Table 54. Global Chronic Urticaria Medicine Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Chronic Urticaria Medicine Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Chronic Urticaria Medicine Revenue Market Share by Type (2021–2026)
Table 57. Global Chronic Urticaria Medicine Revenue Market Share by Type (2027–2032)
Table 58. Global Chronic Urticaria Medicine Price (US$/Unit) by Type (2021–2026)
Table 59. Global Chronic Urticaria Medicine Price (US$/Unit) by Type (2027–2032)
Table 60. Global Chronic Urticaria Medicine Sales (K Units) by Application (2021–2026)
Table 61. Global Chronic Urticaria Medicine Sales (K Units) by Application (2027–2032)
Table 62. Global Chronic Urticaria Medicine Sales Market Share by Application (2021–2026)
Table 63. Global Chronic Urticaria Medicine Sales Market Share by Application (2027–2032)
Table 64. Global Chronic Urticaria Medicine Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Chronic Urticaria Medicine Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Chronic Urticaria Medicine Revenue Market Share by Application (2021–2026)
Table 67. Global Chronic Urticaria Medicine Revenue Market Share by Application (2027–2032)
Table 68. Global Chronic Urticaria Medicine Price (US$/Unit) by Application (2021–2026)
Table 69. Global Chronic Urticaria Medicine Price (US$/Unit) by Application (2027–2032)
Table 70. Johnson & Johnson Company Information
Table 71. Johnson & Johnson Description and Business Overview
Table 72. Johnson & Johnson Chronic Urticaria Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Johnson & Johnson Chronic Urticaria Medicine Product
Table 74. Johnson & Johnson Recent Developments/Updates
Table 75. Merck Company Information
Table 76. Merck Description and Business Overview
Table 77. Merck Chronic Urticaria Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Merck Chronic Urticaria Medicine Product
Table 79. Merck Recent Developments/Updates
Table 80. Fresenius Company Information
Table 81. Fresenius Description and Business Overview
Table 82. Fresenius Chronic Urticaria Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Fresenius Chronic Urticaria Medicine Product
Table 84. Fresenius Recent Developments/Updates
Table 85. 3SBIO Company Information
Table 86. 3SBIO Description and Business Overview
Table 87. 3SBIO Chronic Urticaria Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. 3SBIO Chronic Urticaria Medicine Product
Table 89. 3SBIO Recent Developments/Updates
Table 90. SPHBIO Company Information
Table 91. SPHBIO Description and Business Overview
Table 92. SPHBIO Chronic Urticaria Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. SPHBIO Chronic Urticaria Medicine Product
Table 94. SPHBIO Recent Developments/Updates
Table 95. Sun Pharmaceutical Industries Company Information
Table 96. Sun Pharmaceutical Industries Description and Business Overview
Table 97. Sun Pharmaceutical Industries Chronic Urticaria Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Sun Pharmaceutical Industries Chronic Urticaria Medicine Product
Table 99. Sun Pharmaceutical Industries Recent Developments/Updates
Table 100. Yangtze River Pharmaceutical Group Company Information
Table 101. Yangtze River Pharmaceutical Group Description and Business Overview
Table 102. Yangtze River Pharmaceutical Group Chronic Urticaria Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Yangtze River Pharmaceutical Group Chronic Urticaria Medicine Product
Table 104. Yangtze River Pharmaceutical Group Recent Developments/Updates
Table 105. CSPC Pharmaceutical Group Company Information
Table 106. CSPC Pharmaceutical Group Description and Business Overview
Table 107. CSPC Pharmaceutical Group Chronic Urticaria Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. CSPC Pharmaceutical Group Chronic Urticaria Medicine Product
Table 109. CSPC Pharmaceutical Group Recent Developments/Updates
Table 110. Shanxi C&Y Pharmaceutical Group Company Information
Table 111. Shanxi C&Y Pharmaceutical Group Description and Business Overview
Table 112. Shanxi C&Y Pharmaceutical Group Chronic Urticaria Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Shanxi C&Y Pharmaceutical Group Chronic Urticaria Medicine Product
Table 114. Shanxi C&Y Pharmaceutical Group Recent Developments/Updates
Table 115. Lianhuan Pharma Company Information
Table 116. Lianhuan Pharma Description and Business Overview
Table 117. Lianhuan Pharma Chronic Urticaria Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Lianhuan Pharma Chronic Urticaria Medicine Product
Table 119. Lianhuan Pharma Recent Developments/Updates
Table 120. Jiudian Pharmaceutical Company Information
Table 121. Jiudian Pharmaceutical Description and Business Overview
Table 122. Jiudian Pharmaceutical Chronic Urticaria Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Jiudian Pharmaceutical Chronic Urticaria Medicine Product
Table 124. Jiudian Pharmaceutical Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Chronic Urticaria Medicine Distributors List
Table 128. Chronic Urticaria Medicine Customers List
Table 129. Chronic Urticaria Medicine Market Trends
Table 130. Chronic Urticaria Medicine Market Drivers
Table 131. Chronic Urticaria Medicine Market Challenges
Table 132. Chronic Urticaria Medicine Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Chronic Urticaria Medicine
Figure 2. Global Chronic Urticaria Medicine Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Chronic Urticaria Medicine Market Share by Type: 2025 & 2032
Figure 4. Loratadine Product Picture
Figure 5. Desloratadine Product Picture
Figure 6. Fexofenadine Product Picture
Figure 7. Ebastine Product Picture
Figure 8. Stastine Product Picture
Figure 9. Cetirizine Product Picture
Figure 10. Levocetirizine Product Picture
Figure 11. Cinnarizine Product Picture
Figure 12. Other Product Picture
Figure 13. Global Chronic Urticaria Medicine Market Value by Application (US$ Million), 2021–2032
Figure 14. Global Chronic Urticaria Medicine Market Share by Application: 2025 & 2032
Figure 15. Hospital and Clinic
Figure 16. Specialist Medical Centre
Figure 17. Retail Pharmacies
Figure 18. Other
Figure 19. Global Chronic Urticaria Medicine Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 20. Global Chronic Urticaria Medicine Market Size (US$ Million), 2021–2032
Figure 21. Global Chronic Urticaria Medicine Sales (K Units), 2021–2032
Figure 22. Global Chronic Urticaria Medicine Average Price (US$/Unit), 2021–2032
Figure 23. Chronic Urticaria Medicine Report Years Considered
Figure 24. Chronic Urticaria Medicine Sales Share by Manufacturers in 2025
Figure 25. Global Chronic Urticaria Medicine Revenue Share by Manufacturers in 2025
Figure 26. Top 5 and Top 10 Global Chronic Urticaria Medicine Players: Market Share by Revenue in Chronic Urticaria Medicine in 2025
Figure 27. Chronic Urticaria Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 28. Global Chronic Urticaria Medicine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 29. North America Chronic Urticaria Medicine Sales Market Share by Country (2021–2032)
Figure 30. North America Chronic Urticaria Medicine Revenue Market Share by Country (2021–2032)
Figure 31. United States Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Canada Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Europe Chronic Urticaria Medicine Sales Market Share by Country (2021–2032)
Figure 34. Europe Chronic Urticaria Medicine Revenue Market Share by Country (2021–2032)
Figure 35. Germany Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. France Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. U.K. Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Italy Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Russia Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Asia Pacific Chronic Urticaria Medicine Sales Market Share by Region (2021–2032)
Figure 41. Asia Pacific Chronic Urticaria Medicine Revenue Market Share by Region (2021–2032)
Figure 42. China Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Japan Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. South Korea Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. India Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Australia Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. China Taiwan Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Southeast Asia Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Latin America Chronic Urticaria Medicine Sales Market Share by Country (2021–2032)
Figure 50. Latin America Chronic Urticaria Medicine Revenue Market Share by Country (2021–2032)
Figure 51. Mexico Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Brazil Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Argentina Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Colombia Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Middle East and Africa Chronic Urticaria Medicine Sales Market Share by Country (2021–2032)
Figure 56. Middle East and Africa Chronic Urticaria Medicine Revenue Market Share by Country (2021–2032)
Figure 57. Turkey Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Saudi Arabia Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 59. UAE Chronic Urticaria Medicine Revenue Growth Rate (US$ Million), 2021–2032
Figure 60. Global Sales Market Share of Chronic Urticaria Medicine by Type (2021–2032)
Figure 61. Global Revenue Market Share of Chronic Urticaria Medicine by Type (2021–2032)
Figure 62. Global Chronic Urticaria Medicine Price (US$/Unit) by Type (2021–2032)
Figure 63. Global Sales Market Share of Chronic Urticaria Medicine by Application (2021–2032)
Figure 64. Global Revenue Market Share of Chronic Urticaria Medicine by Application (2021–2032)
Figure 65. Global Chronic Urticaria Medicine Price (US$/Unit) by Application (2021–2032)
Figure 66. Chronic Urticaria Medicine Value Chain
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232